Pre-developed Stromal Models for Tumor-Stroma Interaction Studies
The novel 3DProSeed ® StromaLine ® developed by Ectica is an advantageous collection of pre-developed and well characterized stromal models
Read moreThe novel 3DProSeed ® StromaLine ® developed by Ectica is an advantageous collection of pre-developed and well characterized stromal models
Read moreFrench pharma giant Sanofi and British pharmatech business Exscientia revealed a ground-breaking research cooperation and licensing agreement to develop up
Read moreEvotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
Read morePfizer’s COVID-19 Antiviral, PAXLOVID, has been authorised for use in people over 18 with mild to moderate COVID-19 and at
Read moreThe award-winning Ireland-based medical device company Aerogen and the innovative Chinese vaccine company CanSinoBIO entered into a partnership earlier this
Read moreVaccine maker Moderna, which is at the forefront of developing messenger RNA (mRNA) therapeutics and vaccines, announced today that according
Read moreEvusheld, a long-acting antibody (LAAB) combination from AstraZeneca, has received emergency use authorisation (EUA) by the FDA in the United
Read morePreliminary laboratory studies have shown that three doses of the Pfizer-BioNTech COVID-19 Vaccine can neutralize the Omicron variant (B.1.1.529 lineage),
Read moreA new Oxford-GSK Institute of Molecular and Computational Medicine will be established through a substantial five-year cooperation between GlaxoSmithKline plc
Read moreLeading vaccine producers have stated that new vaccines will be developed if necessary to meet the demand of governments worldwide
Read more